tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Encompass Health (EHC) and Xencor (XNCR)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GE Healthcare Technologies Inc (GEHCResearch Report), Encompass Health (EHCResearch Report) and Xencor (XNCRResearch Report) with bullish sentiments.

GE Healthcare Technologies Inc (GEHC)

Mizuho Securities analyst Anthony Petrone maintained a Buy rating on GE Healthcare Technologies Inc on September 27 and set a price target of $94.00. The company’s shares closed last Thursday at $69.78.

According to TipRanks.com, Petrone is a 3-star analyst with an average return of 0.7% and a 40.9% success rate. Petrone covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Inspire Medical Systems, and Edwards Lifesciences.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for GE Healthcare Technologies Inc with a $87.89 average price target, representing a 27.9% upside. In a report issued on September 19, Citi also initiated coverage with a Buy rating on the stock with a $82.00 price target.

See the top stocks recommended by analysts >>

Encompass Health (EHC)

In a report issued on September 27, Ann Hynes from Mizuho Securities maintained a Buy rating on Encompass Health, with a price target of $77.00. The company’s shares closed last Thursday at $67.57.

According to TipRanks.com, Hynes is a 5-star analyst with an average return of 7.8% and a 58.3% success rate. Hynes covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Pediatrix Medical Group, and Molina Healthcare.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Encompass Health with a $79.75 average price target, implying a 18.0% upside from current levels. In a report released yesterday, Bank of America Securities also maintained a Buy rating on the stock with a $84.00 price target.

Xencor (XNCR)

Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Xencor on September 27 and set a price target of $59.00. The company’s shares closed last Thursday at $20.50, close to its 52-week low of $20.01.

According to TipRanks.com, Goldstein ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -7.1% and a 31.9% success rate. Goldstein covers the Healthcare sector, focusing on stocks such as Adaptimmune Therapeutics, Iovance Biotherapeutics, and Corvus Pharmaceuticals.

Xencor has an analyst consensus of Moderate Buy, with a price target consensus of $43.33.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on GEHC:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles